Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.0835 | 0.343 | 1 |
Schistosoma mansoni | hypothetical protein | 0.007 | 0.016 | 0.3151 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.007 | 0.016 | 0.0467 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.007 | 0.016 | 0.0467 |
Trichomonas vaginalis | conserved hypothetical protein | 0.2373 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.007 | 0.016 | 0.3151 |
Loa Loa (eye worm) | hypothetical protein | 0.0449 | 0.178 | 0.5191 |
Echinococcus granulosus | mitogen activated protein kinase 14 | 0.0835 | 0.343 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.007 | 0.016 | 0.0467 |
Brugia malayi | Latrophilin receptor protein 2 | 0.007 | 0.016 | 0.0467 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.0835 | 0.343 | 1 |
Onchocerca volvulus | 0.0033 | 0 | 0.5 | |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0298 | 0.1133 | 0.3302 |
Onchocerca volvulus | 0.0033 | 0 | 0.5 | |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0222 | 0.0808 | 0.2356 |
Schistosoma mansoni | hypothetical protein | 0.007 | 0.016 | 0.3151 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.007 | 0.016 | 0.0467 |
Entamoeba histolytica | SH2-protein kinase domain containing protein | 0.0033 | 0 | 0.5 |
Trypanosoma brucei | nucleoside 2-deoxyribosyltransferase | 0.2373 | 1 | 1 |
Echinococcus multilocularis | GPCR, family 2 | 0.007 | 0.016 | 0.0467 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0222 | 0.0808 | 0.2356 |
Schistosoma mansoni | hypothetical protein | 0.0152 | 0.0508 | 1 |
Onchocerca volvulus | 0.0033 | 0 | 0.5 | |
Onchocerca volvulus | 0.0033 | 0 | 0.5 | |
Onchocerca volvulus | 0.0033 | 0 | 0.5 | |
Trypanosoma cruzi | hypothetical protein | 0.2373 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.007 | 0.016 | 0.3151 |
Loa Loa (eye worm) | hypothetical protein | 0.0152 | 0.0508 | 0.1481 |
Echinococcus granulosus | GPCR family 2 | 0.007 | 0.016 | 0.0467 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.2373 | 1 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0298 | 0.1133 | 0.3302 |
Echinococcus granulosus | tyrosine protein kinase Lyn | 0.0036 | 0.0013 | 0.0038 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.0835 | 0.343 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0152 | 0.0508 | 0.1481 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.0835 | 0.343 | 1 |
Loa Loa (eye worm) | CMGC/MAPK/P38 protein kinase | 0.0835 | 0.343 | 1 |
Brugia malayi | P38 map kinase family protein 2 | 0.0835 | 0.343 | 1 |
Onchocerca volvulus | 0.0033 | 0 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.007 | 0.016 | 0.0467 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0449 | 0.178 | 0.5191 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.2373 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein | 0.2373 | 1 | 1 |
Echinococcus granulosus | mitogen activated protein kinase 11 | 0.0835 | 0.343 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.2373 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CC50 (functional) | = 22.2 uM | In vitro inhibition of CEM cell proliferation. | ChEMBL. | 10966745 |
CC50 (functional) | = 22.2 uM | In vitro inhibition of CEM cell proliferation. | ChEMBL. | 10966745 |
CC50 (functional) | > 50 uM | Inhibition of cell growth in HEL cells. | ChEMBL. | 10966745 |
CC50 (functional) | > 50 uM | Inhibition of cell growth in HEL cells. | ChEMBL. | 10966745 |
CC50 (functional) | > 56 uM | Cytotoxicity against Human cytomegalovirus (AD169) strain(HCMV) | ChEMBL. | 10560739 |
EC50 (functional) | > 10 uM | In vitro inhibition of HIV-1(IIIB) cytopathicity in CEM cells. | ChEMBL. | 10966745 |
EC50 (functional) | > 10 uM | In vitro inhibition of HIV-2(ROD) cytopathicity in CEM cells. | ChEMBL. | 10966745 |
IC50 (functional) | = 8 uM | In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (YS/R) plaque formation. | ChEMBL. | 10966745 |
IC50 (functional) | = 10 uM | In vitro inhibition of HCMV (AD-169) plaque formation. | ChEMBL. | 10966745 |
IC50 (functional) | = 10 uM | In vitro inhibition of HCMV (Davis) plaque formation. | ChEMBL. | 10966745 |
IC50 (functional) | = 18 uM | Antiviral activity against Human cytomegalovirus (AD169) strain(HCMV) | ChEMBL. | 10560739 |
IC50 (functional) | > 50 uM | In vitro inhibition of Thymidine Kinase-Varicella-Zoster Virus(OKA) plaque formation. | ChEMBL. | 10966745 |
IC50 (functional) | > 50 uM | In vitro inhibition of Thymidine Kinase-Varicella Zoster Virus(YS) plaque formation. | ChEMBL. | 10966745 |
IC50 (functional) | > 50 uM | In vitro inhibition of Thymidine Kinase deficient Varicella Zoster Virus (07/1) plaque formation. | ChEMBL. | 10966745 |
MCC (functional) | = 200 uM | In vitro alteration in cell morphology in HEL cells. | ChEMBL. | 10966745 |
MCC (functional) | = 200 uM | In vitro alteration in cell morphology in HEL cells. | ChEMBL. | 10966745 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.